Ruxience 500 MG/50 ML vial 50ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV233
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,466
Award facts
- Contract value 100% obligated
- $3,465.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ruxience 500 mg/50 mL vials, a biosimilar monoclonal antibody used in oncology and immunology treatment regimens. This competitively awarded, non-set-aside contract carries a ceiling value of $3,465.55 and was executed on January 5, 2026, with an ultimate completion date of January 6, 2026. The contract operates under firm fixed pricing terms and represents a single delivery order fulfillment through AmerisourceBergen's existing pharmaceutical supply vehicle.
This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, AmerisourceBergen serves as a critical federal healthcare vendor supplying the Defense Health Agency, U.S. Coast Guard, and other government medical systems. The company's DLA prime contract provides comprehensive global pharmaceutical support across multiple therapeutic domains, enabling flexible procurement of specialty medications, brand-name and generic drugs, vaccines, and associated medical supplies to support military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26FV233?
SPE2DR26FV233 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FV233 worth?
The government has obligated $3,466 on SPE2DR26FV233.
Is contract SPE2DR26FV233 an order under another contract?
Yes. SPE2DR26FV233 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV233 competed?
The extent of competition for SPE2DR26FV233 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award